The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing

Biomaterials

Volumn 34, Issue 35, 2013, Pages 8887-8898

  Hoffman, Michael D ^a,b   Xie, Chao ^b   Zhang, Xinping ^b   Benoit, Danielle S W ^a,b  

^a University of Rochester   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bone allografts; Hydrogels; Mesenchymal stem cells; Periosteum; Regenerative medicine; Tissue engineering

Indexed keywords

BONE ALLOGRAFTS; CELL POPULATIONS; DEGRADABLE HYDROGEL; ENDOCHONDRAL OSSIFICATION; MESENCHYMAL STEM CELL; PERIOSTEUM; REGENERATIVE MEDICINE; SMALL-MOLECULE DRUGS;

BIOMATERIALS; BONE; CELL PROLIFERATION; GRAFTS; HYDROGELS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CELL CULTURE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BIOMECHANICS; BIOMIMETICS; BONE ALLOGRAFT; BONE DEFECT; BONE GRAFT; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FEMALE; GOLD STANDARD; HYDROGEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PERIOSTEUM TRANSPLANTATION; PRIORITY JOURNAL; TISSUE ENGINEERING;

BONE ALLOGRAFTS; HYDROGELS; MESENCHYMAL STEM CELLS; PERIOSTEUM; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

ALLOGRAFTS; BONE AND BONES; BONE TRANSPLANTATION; HUMANS; HYDROGELS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PERIOSTEUM; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING;

EID: 84883225977     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.005     Document Type: Article

References (70)

1. Farfalli G.L., Aponte-Tinao L., Lopez-Millan L., Ayerza M.A., Muscolo D.L. Clinical and functional outcomes of tibial intercalary allografts after tumor resection. Orthopedics 2012, 35(3):e391-e396.
2. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury 2005, 36(Suppl.3):S20-S27.
3. Greenwald A.S., Boden S.D., Goldberg V.M., Khan Y., Laurencin C.T., Rosier R.N. Bone-graft substitutes: facts, fictions, and applications. JBone Jt Surg Am 2001, 83-A(Suppl.2 Pt 2):98-103.
4. Xie C., Reynolds D., Awad H., Rubery P.T., Pelled G., Gazit D., et al. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng 2007, 13(3):435-445.
5. Zhang X., Xie C., Lin A.S., Ito H., Awad H., Lieberman J.R., et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. JBone Miner Res 2005, 20(12):2124-2137.
6. Sasso R.C., LeHuec J.C., Shaffrey C. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. JSpinal Disord Tech 2005, 18(Suppl.):S77-S81.
7. Hornicek F.J., Gebhardt M.C., Tomford W.W., Sorger J.I., Zavatta M., Menzner J.P., et al. Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res 2001, 382:87-98.
8. Wheeler D.L., Enneking W.F. Allograft bone decreases in strength invivo over time. Clin Orthop Relat Res 2005, 435:36-42.
9. Mankin H.J., Hornicek F.J., Raskin K.A. Infection in massive bone allografts. Clin Orthop Relat Res 2005, 432:210-216.
10. Zhang X., Awad H.A., O'Keefe R.J., Guldberg R.E., Schwarz E.M. Aperspective: engineering periosteum for structural bone graft healing. Clin Orthop Relat Res 2008, 466(8):1777-1787.
11. Hoffman M.D., Benoit D.S. Emerging ideas: engineering the periosteum: revitalizing allografts by mimicking autograft healing. Clin Orthop Relat Res 2013, 471(3):721-726.
12. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. JBone Miner Res 2009, 24(2):274-282.
13. Malizos K.N., Papatheodorou L.K. The healing potential of the periosteum molecular aspects. Injury 2005, 36(Suppl.3):S13-S19.
14. Chang H., Knothe Tate M.L. Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells. Stem Cells Transl Med 2012, 1(6):480-491.
15. Evans S.F., Chang H., Knothe Tate M.L. Elucidating multiscale periosteal mechanobiology: a key to unlocking the smart properties and regenerative capacity of the periosteum?. Tissue Eng Part B Rev 2013, 19(2):147-159.
16. Hutmacher D.W., Sittinger M. Periosteal cells in bone tissue engineering. Tissue Eng 2003, 9(Suppl.1):S45-S64.
17. Bielby R., Jones E., McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 2007, 38(Suppl.1):S26-S32.
18. Dwek J.R. The periosteum: what is it, where is it, and what mimics it in its absence?. Skeletal Radiol 2010, 39(4):319-323.
19. Ito H., Koefoed M., Tiyapatanaputi P., Gromov K., Goater J.J., Carmouche J., et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005, 11(3):291-297.
20. Rodrigues M., Griffith L.G., Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 2010, 1(4):32.
21. Schonmeyr B., Clavin N., Avraham T., Longo V., Mehrara B.J. Synthesis of a tissue-engineered periosteum with acellular dermal matrix and cultured mesenchymal stem cells. Tissue Eng Part A 2009, 15(7):1833-1841.
22. Yazici C., Takahata M., Reynolds D.G., Xie C., Samulski R.J., Samulski J., et al. Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur. Mol Ther 2011, 19(8):1416-1425.
23. Tiyapatanaputi P., Rubery P.T., Carmouche J., Schwarz E.M., O'Keefe R.J., Zhang X. Anovel murine segmental femoral graft model. JOrthop Res 2004, 22(6):1254-1260.
24. Devescovi V., Leonardi E., Ciapetti G., Cenni E. Growth factors in bone repair. Chir Organi Mov 2008, 92(3):161-168.
25. Han S.K., Yoon T.H., Lee D.G., Lee M.A., Kim W.K. Potential of human bone marrow stromal cells to accelerate wound healing invitro. Ann Plast Surg 2005, 55(4):414-419.
26. Pluhar G.E., Manley P.A., Heiner J.P., Vanderby R., Seeherman H.J., Markel M.D. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. JOrthop Res 2001, 19(2):308-317.
27. Takahata M., Awad H.A., O'Keefe R.J., Bukata S.V., Schwarz E.M. Endogenous tissue engineering: PTH therapy for skeletal repair. Cell Tissue Res 2012, 347(3):545-552.
28. Reynolds D.G., Takahata M., Lerner A.L., O'Keefe R.J., Schwarz E.M., Awad H.A. Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model. Bone 2011, 48(3):562-570.
29. Murphy W.L., Peters M.C., Kohn D.H., Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2000, 21(24):2521-2527.
30. Derner R., Anderson A.C. The bone morphogenic protein. Clin Podiatr Med Surg 2005, 22(4):607-618. [vii].
31. Awad H.A., Zhang X., Reynolds D.G., Guldberg R.E., O'Keefe R.J., Schwarz E.M. Recent advances in gene delivery for structural bone allografts. Tissue Eng 2007, 13(8):1973-1985.
32. Bonewald L.F., Dallas S.L. Role of active and latent transforming growth factor beta in bone formation. JCell Biochem 1994, 55(3):350-357.
33. Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. JCell Biochem 1997, 64(2):278-294.
34. Ellender G., Feik S.A., Carach B.J. Periosteal structure and development in a rat caudal vertebra. JAnat 1988, 158:173-187.
35. Ham A.W. Ahistological study in the early phases of bone repair. JBone Jt Surg Am 1930, 12:827-844.
36. Squier C.A., Ghoneim S., Kremenak C.R. Ultrastructure of the periosteum from membrane bone. JAnat 1990, 171:233-239.
37. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8(9):726-736.
38. Choi Y.S., Noh S.E., Lim S.M., Lee C.W., Kim C.S., Im M.W., et al. Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett 2008, 30(4):593-601.
39. Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., Quarto R. Proliferation kinetics and differentiation potential of exvivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 2000, 28(6):707-715.
40. Murphy J.M., Fink D.J., Hunziker E.B., Barry F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003, 48(12):3464-3474.
41. Elisseeff J., Puleo C., Yang F., Sharma B. Advances in skeletal tissue engineering with hydrogels. Orthod Craniofac Res 2005, 8(3):150-161.
42. Benoit D.S., Tripodi M.C., Blanchette J.O., Langer S.J., Leinwand L.A., Anseth K.S. Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. JBiomed Mater Res A 2007, 81(2):259-268.
43. Lin C.C., Anseth K.S. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 2009, 26(3):631-643.
44. Nuttelman C.R., Tripodi M.C., Anseth K.S. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol 2005, 24(3):208-218.
45. Benoit D.S.W., Collins S.D., Anseth K.S. Multifunctional hydrogels that promote osteogenic human mesenchymal stem cell differentiation through stimulation and sequestering of bone morphogenic protein 2. Adv Funct Mater 2007, 17(13):2085-2093.
46. Benoit D.S.W., Nuttelman C.R., Collins S.D., Anseth K.S. Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 2006, 27(36):6102-6110.
47. Nuttelman C.R., Tripodi M.C., Anseth K.S. Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs. JBiomed Mater Res A 2006, 76(1):183-195.
48. Sawhney A.S., Pathak C.P., Hubbell J.A. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(alpha-hydroxy acid) diacrylate macromers. Macromolecules 1993, 26(4):581-587.
49. Hoffman M.D., Benoit D.S. Agonism of Wnt-beta-catenin signalling promotes mesenchymal stem cell (MSC) expansion. JTissue Eng Regen Med 2013.
50. Lin-Gibson S., Bencherif S., Cooper J.A., Wetzel S.J., Antonucci J.M., Vogel B.M., et al. Synthesis and characterization of PEG dimethacrylates and their hydrogels. Biomacromolecules 2004, 5(4):1280-1287.
51. Benoit D.S., Boutin M.E. Controlling mesenchymal stem cell gene expression using polymer-mediated delivery of siRNA. Biomacromolecules 2012, 13(11):3841-3849.
52. Benoit D.S.W., Durney A.R., Anseth K.S. The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. Biomaterials 2007, 28(1):66-77.
53. Benoit D.S.W., Schwartz M.P., Durney A.R., Anseth K.S. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 2008, 7(10):816-823.
54. Fairbanks B.D., Schwartz M.P., Bowman C.N., Anseth K.S. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials 2009, 30(35):6702-6707.
55. Reynolds D.G., Hock C., Shaikh S., Jacobson J., Zhang X., Rubery P.T., et al. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. JBiomech 2007, 40(14):3178-3186.
56. Reynolds D.G., Shaikh S., Papuga M.O., Lerner A.L., O'Keefe R.J., Schwarz E.M., et al. muCT-based measurement of cortical bone graft-to-host union. JBone Miner Res 2009, 24(5):899-907.
57. Duvall C.L., Taylor W.R., Weiss D., Guldberg R.E. Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol 2004, 287(1):H302-H310.
58. Brodt M.D., Ellis C.B., Silva M.J. Growing C57Bl/6 mice increase whole bone mechanical properties by increasing geometric and material properties. JBone Miner Res 1999, 14(12):2159-2166.
59. Benoit D.S., Durney A.R., Anseth K.S. Manipulations in hydrogel degradation behavior enhance osteoblast function and mineralized tissue formation. Tissue Eng 2006, 12(6):1663-1673.
60. Metters A.T., Anseth K.S., Bowman C.N. Fundamental studies of biodegradable hydrogels as cartilage replacement materials. Biomed Sci Instrum 1999, 35:33-38.
61. Henriksen K., Karsdal M., Delaisse J.M., Engsig M.T. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. JBiol Chem 2003, 278(49):48745-48753.
62. Burchardt H. The biology of bone graft repair. Clin Orthop Relat Res 1983, 174:28-42.
63. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, (355 Suppl.):S7-S21.
64. Takahata M., Schwarz E.M., Chen T., O'Keefe R.J., Awad H.A. Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction. JBone Miner Res 2012, 27(1):26-37.
65. Yang Q., McHugh K.P., Patntirapong S., Gu X., Wunderlich L., Hauschka P.V. VEGFenhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol 2008, 27(7):589-599.
66. Barnes G.L., Kakar S., Vora S., Morgan E.F., Gerstenfeld L.C., Einhorn T.A. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. JBone Jt Surg Am 2008, 90(Suppl.1):120-127.
67. Nakazawa T., Nakajima A., Shiomi K., Moriya H., Einhorn T.A., Yamazaki M. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Bone 2005, 37(5):711-719.
68. Nakajima A., Shimoji N., Shiomi K., Shimizu S., Moriya H., Einhorn T.A., et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). JBone Miner Res 2002, 17(11):2038-2047.
69. Ma D., Yao H., Tian W., Chen F., Liu Y., Mao T., et al. Enhancing bone formation by transplantation of a scaffold-free tissue-engineered periosteum in a rabbit model. Clin Oral Implants Res 2011, 22(10):1193-1199.
70. Ma D., Ren L., Liu Y., Chen F., Zhang J., Xue Z., et al. Engineering scaffold-free bonetissue using bone marrow stromal cell sheets. JOrthop Res 2010, 28(5):697-702.